Bunion Clinical Trial
Official title:
A Phase 3, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study to Evaluate the Analgesic Efficacy and Safety of Intra-operative Administration of PRF-110 Following Unilateral Bunionectomy
PRF-110 is a viscous, yellowish clear oily solution of ropivacaine intended for administration into surgical sites to provide post-operative analgesia. The pharmacokinetic profile for PRF-110 suggests that its effect could last up to 72 hours. This is A Phase 3, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study to Evaluate the Analgesic Efficacy and Safety of Intra-operative Administration of PRF-110 Following Unilateral Bunionectomy
PRF-110 is a unique, sustained-release, oil-based solution formulation of ropivacaine intended for administration into surgical sites for the prevention of postoperative pain. The formulation is designed to have an effect for up to 72 hours. It is postulated that PRF-110 will improve postoperative pain management by providing prolonged pain relief at the surgical site; thereby, reducing the amount of systemic analgesia needed after surgery. The slow, local release of ropivacaine following administration of PRF-110 has been demonstrated in dissolution studies, in postoperative pain studies in animals, in an experimental pain study in human volunteers, and in an open-label Phase 2 hernia repair trial to result in very low plasma concentrations of drug, therefore reducing the probability of systemic adverse events. This is a randomized, double-blind study to evaluate the efficacy and safety of PRF-110 compared with saline placebo and with ropivacaine hydrochloride injection administered intraoperatively in subjects undergoing unilateral bunionectomy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01435577 -
Intravenous Tapentadol in Post-Bunionectomy Pain
|
Phase 2 | |
| Terminated |
NCT05082012 -
Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D)
|
N/A | |
| Terminated |
NCT03257540 -
Early Weight-Bearing After Lapidus Arthrodesis
|
||
| Completed |
NCT04518462 -
Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries
|
Phase 3 | |
| Completed |
NCT04084262 -
Multi-Plane Hallux Valgus Correction With the Phantom® Nail
|
||
| Active, not recruiting |
NCT03740282 -
Early Weight-Bearing After the Lapiplasty Procedure
|
N/A | |
| Completed |
NCT01743625 -
Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain
|
Phase 3 | |
| Completed |
NCT01484652 -
Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension
|
Phase 3 | |
| Recruiting |
NCT05831449 -
CPL-01 in the Management of Postoperative Pain After Bunionectomy
|
Phase 3 | |
| Terminated |
NCT01133639 -
Ketorolac Effects on Post-operative Pain and Bone Healing
|
N/A | |
| Completed |
NCT04826328 -
Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy
|
Phase 1 | |
| Completed |
NCT03653429 -
Efficacy of Tranexamic Acid in Foot and Ankle Surgeries
|
Phase 4 | |
| Recruiting |
NCT04751344 -
Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery
|
Phase 4 | |
| Withdrawn |
NCT03954639 -
Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries
|
Phase 3 | |
| Completed |
NCT04002089 -
Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy
|
Phase 1 | |
| Terminated |
NCT02499575 -
Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures
|
N/A | |
| Completed |
NCT00613938 -
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.
|
Phase 3 | |
| Completed |
NCT03246971 -
Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain
|
Phase 2 | |
| Completed |
NCT00890682 -
Study of Postoperative Analgesia in Bunionectomy
|
Phase 3 | |
| Active, not recruiting |
NCT05602844 -
Clinical Trial on Patient-Specific-Instrumentation Assisted Lapidus Fusion for Hallux Valgus
|
N/A |